Rewalk Stock Story

RWLK
 Stock
  

USD 0.94  0.03  3.09%   

Today we may see the proof that Dexcom would recover much slower from the new pull down as its shares went up 7.45% to Rewalk Robotics's 7.9545%. As many rational traders are trying to avoid healthcare space, it makes sense to examine Rewalk Robotics a little further and understand how it stands against Dexcom and other similar entities. We are going to concentrate on some of the competitive aspects of both Rewalk and Dexcom.
Published over a month ago
View all stories for Rewalk Robotics | View All Stories

Rewalk Robotics Current Investor Sentiment

Investor biases related to Rewalk Robotics' public news can be used to forecast risks associated with investment in Rewalk. The trend in average sentiment can be used to explain how an investor holding Rewalk can time the market purely based on public headlines and social activities around Rewalk Robotics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Rewalk Robotics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Rewalk Robotics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Rewalk Robotics' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Rewalk Robotics.
Will Rewalk Robotics (NASDAQ:RWLK) traders shift to Dexcom (NASDAQ:DXCM)?
By analyzing existing essential indicators between Rewalk Robotics and Dexcom, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in Dexcom with a short position in Rewalk Robotics. Check out our pair correlation module for more information.

Let's begin by analyzing the assets.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Rewalk Robotics has an asset utilization ratio of 23.23 percent. This signifies that the company is making $0.23 for each dollar of assets. An increasing asset utilization means that Rewalk Robotics is more efficient with each dollar of assets it utilizes for everyday operations.

Watch out for price decline

Please consider monitoring Rewalk Robotics on a daily basis if you are holding a position in it. Rewalk Robotics is trading at a penny-stock level, and the possibility of delisting is much higher compared to other equities. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion. Most exchanges require public instruments, such as Rewalk Robotics stock to be traded above the $1 level to remain listed. If Rewalk Robotics stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.

How important is Rewalk Robotics's Liquidity

Rewalk Robotics financial leverage refers to using borrowed capital as a funding source to finance Rewalk Robotics ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Rewalk Robotics financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Rewalk Robotics's total debt and its cash.

How does Rewalk utilize its cash?

To perform a cash flow analysis of Rewalk Robotics, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Rewalk Robotics is receiving and how much cash it distributes out in a given period. The Rewalk Robotics cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

An Additional Perspective On Rewalk Robotics

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Lets now take a look at Rewalk Robotics revenue. Based on the latest financial disclosure, Rewalk Robotics reported 5.94 M of revenue. This is 99.92% lower than that of the Healthcare sector and 99.77% lower than that of the Medical Devices industry. The revenue for all United States stocks is 99.94% higher than that of the company. As for Dexcom we see revenue of 2.32 B, which is 9.05% lower than that of the Medical Devices

Sector
2.6 B
DXCM
2.3 B
RWLK5.94 Million0.12
Sector2.55 Billion52.31
DXCM2.32 Billion47.57

Our perspective of the recent Rewalk Robotics surge

Recent Total Risk Alpha is up to -0.05. Price may plunge again.
As of the 13th of May 2022, Rewalk Robotics holds the risk adjusted performance of (0.18), and Coefficient Of Variation of (687.94). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rewalk Robotics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Rewalk Robotics, which can be compared to its competitors. Please check Rewalk Robotics coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Rewalk Robotics is priced some-what accurately, providing market reflects its current price of 0.95 per share. Given that Rewalk Robotics is a hitting penny stock territory we advise to closely look at its total risk alpha.

Although some firms in the medical devices industry are either recovering or due for a correction, Rewalk Robotics may not be performing as strong as the other in terms of long-term growth potentials. The inconsistency in the assessment between current Rewalk valuation and our trade advice on Rewalk Robotics is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Rewalk Robotics.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Rewalk Robotics. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com